We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polystyrene microplastics disrupt osteogenic differentiation via lysosome-mediated mitochondrial dysfunction: Protective role of mTOR signaling
Summary
Researchers identified a mechanistic pathway by which polystyrene microplastics impair bone formation in zebrafish and mouse preosteoblasts: PS-MPs accumulate in lysosomes, trigger mitochondrial dysfunction, and suppress osteogenic differentiation. Activation of the mTOR signaling pathway was found to partially protect against this bone toxicity.
Polystyrene microplastics (PS-MPs), increasingly detected in aquatic environments, raise health concerns for humans and animals. However, their specific cellular effects remain incompletely characterized. This study identifies a mechanistic pathway by which PS-MPs impair osteogenic differentiation via organelle-specific stress responses in zebrafish larvae and MC3T3-E1 preosteoblasts. PS-MP exposure delayed vertebral mineralization and downregulation of key osteogenic makers. Mechanistically, PS-MPs were internalized through clathrin-mediated endocytosis, transported via the endo -lysosomal system, and accumulated within lysosomes. Lysosomal accumulation of PS-MPs induced lysosomal membrane permeabilization, indicated by increaed colocalization of galectin-3 and lysosomeassociated membrane protein 1, leading to oxidative stress. The resulting mitochondrial dysfunction included initial compensatory fusion responses, followed by impaired mitochondrial dynamics and suppressed mitochondrial biogenesis. These effects were accompanied by activation of PTEN-induced kinase 1/Parkin-mediated mitophagy and exacerbated lysomal stress. Notably, pharmacological activation of mammalian target of rapamycin (mTOR) signaling with MHY1485 restored mitochondrial abundance, upregulated peroxisome proliferator-activated receptor gamma coactivator 1-alpha, reduced mitophagy, and stabilized lysomal membrane integrity–without altering PS-MP uptake. Collectively, these findings reveal a novel organelle-to-organelle stress axis initiated by PS-MP exposure and suggest mTOR activation as a potential therapeutic approach to mitigate PS-MP-induced cellular dysfunction. • PS-MPs impair skeletal development and are internalized through clathrin-mediated endocytosis, trafficking along the Rab5–Rab7–lysosome axis. • Intracellular PS-MP accumulation causes lysosomal membrane permeabilization and structural damage, followed by autophagy-dependent recovery. • PS-MP exposure disrupts mitochondrial dynamics, suppresses mitochondrial biogenesis, and enhances mitophagy. • mTOR pathway inhibition mediates PS-MP–induced defects in mitochondrial homeostasis.